Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

ENOV stock hub

Enovis Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ENOVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.5B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

ENOV

In the news

Latest news · ENOV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E7

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-55.3

P25 -105.6P50 -46.5P75 -3.1

ROIC2.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ENOV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

240

Groups with data

Currency

USD

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001420800
Company name	Enovis Corporation
Country	United States
Country code	US
Cusip	194014502
Employees	7,802
Employees Change	435%
Employees Change Percent	5.9
Enterprise value	$2.9B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	2008-05-08
Isin	US1940145022
Last refreshed	2026-05-10
Market cap	$1.5B
Market cap category	Small-Cap
Price	$26.52
Price currency	USD
Rev Per Employee	292,023.33x
Sector	Healthcare
Sic	3842
Symbol	ENOV
Website	https://www.enovis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-74.5%
EV Sales Forward	1.19x
EV/EBIT	38.23x
EV/EBITDA	7.8x
EV/FCF	80.84x
EV/Sales	1.27x
FCF yield	2.35%
Forward P/E	7.01x
P/B ratio	1.03x
P/S ratio	0.67x
PS Forward	0.63x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.33%
EBITDA Margin	16.34%
FCF margin	1.58%
Gross margin	61%
Gross Profit	$1.4B
Gross Profit Growth	7.59%
Gross Profit Growth Q	6.13%
Gross Profit Growth3 Y	15.04%
Gross Profit Growth5 Y	4.49%
Net Income	$-1.1B
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-48.34%
Profit Margin	-49.91%
Profit Per Employee	$-145,762
ROA	1.09
Roa5y	0.4
ROCE	2.36
ROE	-55.35
Roe5y	-18.18
ROIC	2.67
Roic5y	0.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-4.87%
Cagr15y	-2.04%
Cagr1y	-22.56%
Cagr3y	-22.7%
Cagr5y	-18.54%
EPS Growth Quarters	2
EPS Growth Years	0
FCF Growth5 Y	-30.52%
OCF Growth	64.01%
OCF Growth10 Y	-2.76%
OCF Growth5 Y	-5.95%
Revenue Growth	5.96x
Revenue Growth Q	5.43x
Revenue Growth Quarters	16x
Revenue Growth Years	5x
Revenue Growth3 Y	12.65x
Revenue Growth5 Y	-2.35x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.52
Assets	$3.8B
Cash	$33.1M
Current Assets	$1.2B
Current Liabilities	$608.7M
Debt	$1.4B
Debt EBITDA	$3.57
Debt Equity	$0.95
Debt FCF	$39.27
Equity	$1.5B
Interest Coverage	0.93
Liabilities	$2.4B
Long Term Assets	$2.6B
Long Term Liabilities	$1.7B
Net Cash	$-1.4B
Net Cash By Market Cap	$-90.23
Net Debt EBITDA	$3.7
Net Debt Equity	$0.93
Net Debt FCF	$38.34
Tangible Book Value	$-427.5M
Tangible Book Value Per Share	$-7.43
WACC	8.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.04
Inventory Turnover	1.5
Net Working Capital	$658.1M
Quick ratio	0.78
Working Capital	$631M
Working Capital Turnover	$3.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.49%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-39.3%
1Y total return	-22.55%
200-day SMA	27.12
3Y total return	-53.82%
50-day SMA	23.93
50-day SMA vs 200-day SMA	50under200
5Y total return	-64.12%
All Time High	226.1
All Time High Change	-88.27%
All Time High Date	2014-06-09
All Time Low	15.99
All Time Low Change	65.85%
All Time Low Date	2009-03-09
ATR	1.39
Beta	1.52
Beta1y	2.38
Beta2y	1.53
Ch YTD	-0.45
High	27.89
High52	37.85
High52 Date	2025-05-13
High52ch	-29.93%
Low	26.23
Low52	21
Low52 Date	2026-01-29
Low52ch	26.29%
Ma50ch	10.84%
Premarket Change Percent	0.37
Premarket Price	$27.35
Premarket Volume	403
Price vs 200-day SMA	-2.19%
RSI	60.83
RSI Monthly	38.39
RSI Weekly	51.71
Sharpe ratio	-0.27x
Sortino ratio	-0.28
Total Return	-2.49%
Tr YTD	-0.45
Tr15y	-26.61%
Tr1m	17.76%
Tr1w	12.28%
Tr3m	17.4%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	1
Analyst Price Target Top	$50
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$0.81
Earnings EPS Estimate Growth	0
Earnings Revenue Estimate	571,600,192x
Earnings Revenue Estimate Growth	2.28x
Operating Income	$76M
Operating Income Growth	-12.42
Operating Income Growth Q	5.69
Operating Income Growth5 Y	-11.24
Operating margin	3.33
Price target	$46.67
Price Target Change	$75.98
Price Target Change Top	$88.54

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	56,750,780%
Float Percent	98.59%
Net Borrowing	-65,753,000
Shares Insiders	1.39%
Shares Institutions	117.92%
Shares Out	57,562,603
Shares Qo Q	0.18%
Shares Yo Y	2.49%
Short Float	15.12%
Short Ratio	11.6
Short Shares	14.91

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$1.7M
Average Volume	986,792.55x
Bv Per Share	25.66
CAPEX	$-206.9M
Ch10y	-65.2
Ch15y	-57.92
Ch1m	17.76
Ch1w	12.28
Ch1y	-22.55
Ch3m	17.4
Ch3y	-53.82
Ch5y	-79.43
Ch6m	-5.49
Change	-2.68%
Change From Open	-2.64
Close	27.25
Days Gap	-0.04
Depreciation Amortization	296,298,000
Dollar Volume	40,783,808.5
Earnings Date	2026-05-07
Earnings Time	bmo
EBIT	$76M
EBITDA	$372.2M
EPS	$-19.88
F Score	6
FCF	$35.9M
FCF EV Yield	1.24x
FCF Per Share	$0.62
Financing CF	-77,568,000
Fiscal Year End	December
Founded	1,995
Goodwill	711,903,000
Income Tax	$33.1M
Investing CF	-171,947,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-04-03
Last Split Date	2022-04-05
Last Split Type	Reverse
Last10k Filing Date	2026-02-26
Ma150	26.18
Ma150ch	1.31%
Ma20	24.55
Ma20ch	8.01%
Net CF	-5,331,000
Next Earnings Date	2026-08-06
Open	27.24
Optionable	Yes
P FCF Ratio	42.5
P OCF Ratio	6.29
Position In Range	17.47
Ppne	594,221,000
Pre Close	27.25
Price Date	2026-05-08
Price EBITDA	$4.1
Relative Volume	1.56x
Revenue	2,278,366,000x
SBC By Revenue	1.5x
Share Based Comp	34,265,000
Tax By Revenue	1.45x
Tr6m	-5.49%
Us State	Delaware
Volume	1,537,851
Z Score	0.74

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ENOV pay a dividend?

Capital-return profile for this ticker.

Performance

ENOV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ENOV?

Insider, institutional, and short-interest positioning.

Institutional ownership

+117.9%

Float: +98.6% of shares outstanding

Insider ownership

+1.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ENOV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

60.8

Neutral momentum band

Price vs 200-day MA

-2.2%

50/200-day relationship not available

Beta (5Y)

1.52

More volatile than the market

Sharpe ratio

-0.27

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ENOV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ENOV stock rating?

Enovis Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ENOV analysis?

The full report lives at /stocks/ENOV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ENOV?

The latest report frames ENOV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ENOV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.